Effect of antisense RNA targeting Polo-like kinase 1 on cell growth in A549 lung cancer cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 1, 2008, Pages 22-26

  Zhou, Qiong ^a   Su, Yuan ^a   Bai, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antisense RNA; Cell cycle; Lung cancer; Polo like kinase 1; Proliferation

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY RNA; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL CYCLE; CELL PROLIFERATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; METHODOLOGY; TIME; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MODELS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, ANTISENSE; TIME FACTORS; TRANSFECTION;

EID: 39349093230     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0106-9     Document Type: Article

References (11)

1. Donaldson M M, Tavares A A, Hagan I M et al. The mitotic roles of Polo-like kinase. J Cell Sci, 2001,114(Pt 13):2357-2358
2. van Vugt M A, Bras A, Medema R H. Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res, 2005,65(10):7037-7040
3. Takai N, Hamanaka R, Yoshimatsu J et al. Polo-like kinases (Plks) and cancer. Oncogene, 2005,24(2):287-291
4. Jung M, Grunberg S, Timblin C et al. Paclitaxel and vinorelbine cause synergistic increase in apoptosis but not in microtubular disruption in human lung adenocaconoma cells (A-549). Histochem Cell Biol, 2004,121(2):115-121
5. van Vugt M A, Smits V A, Klompmarker R et al. Inhibition of Polo-like kinase-1 by DNA damage occurs in an ATM-or ATR-dependent fashion. J Biol Chem, 2001, 276(45): 41 656-41660
6. Roshak A K, Capper E A, Imburgia C et al. The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal, 2000,12(6):405-411
7. Toyoshima-Morimoto F, Taniguchi E, Nishida E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep, 2002,3(4):341-348
8. Liu X, Erikson R L. Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc Natl Acad Sci, 2002,99(13):8672-8676
9. van Vugt M A, Van De Weerdt B C, Vader G et al. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J Biol Chem, 2004,279(35):36 841-36 854
10. Liu X, Erikson R L. Polo-like kinase (plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acac Sci USA, 2003,100(10):5789-5794
11. Ando K, Ozaki T, Yamamoto H et al. Polo-like kinase 1(Plk1) inhibits p53 function by physical interaction and phosphorylation. J Biol Chem, 2004,279(24):25 549-25 561